Clinical development of listeria monocytogenes–based immunotherapies

DT Le, TW Dubensky Jr, DG Brockstedt - Seminars in oncology, 2012 - Elsevier
Active immunotherapy targeting dendritic cells (DCs) has shown great promise in preclinical
models and in human clinical trials for the treatment of malignant disease. Sipuleucel-T …
被引用次数：80 相关文章

[引用][C] Clinical Development of Listeria monocytogenes―Based Immunotherapies

DT LE, TW DUBENSKY… - Seminars in …, 2012 - pascal-francis.inist.fr
Clinical Development of Listeria monocytogenes―Based Immunotherapies CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Clinical development of listeria monocytogenes-based immunotherapies

DT Le, TW Dubenksy, DG Brockstedt - Seminars in oncology, 2012 - pure.johnshopkins.edu
Active immunotherapy targeting dendritic cells (DCs) has shown great promise in preclinical
models and in human clinical trials for the treatment of malignant disease. Sipuleucel-T …

Clinical development of Listeria monocytogenes-based immunotherapies.

DT Le, TW Dubenksy Jr, DG Brockstedt - Seminars in Oncology, 2012 - europepmc.org
Active immunotherapy targeting dendritic cells (DCs) has shown great promise in preclinical
models and in human clinical trials for the treatment of malignant disease. Sipuleucel-T …

[引用][C] Clinical Development of Listeria monocytogenes–Based Immunotherapies

DT Le, TW Dubensky, DG Brockstedt - Seminars in Oncology, 2012 - cir.nii.ac.jp
Clinical Development of Listeria monocytogenes–Based Immunotherapies | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Clinical development of Listeria monocytogenes-based immunotherapies

DT Le, TW Dubenksy Jr… - Seminars in …, 2012 - pubmed.ncbi.nlm.nih.gov
Active immunotherapy targeting dendritic cells (DCs) has shown great promise in preclinical
models and in human clinical trials for the treatment of malignant disease. Sipuleucel-T …
[HTML] nih.gov

[HTML][HTML] Clinical Development of Listeria monocytogenes–Based Immunotherapies

DT Le, TW Dubensky Jr, DG Brockstedt - Seminars in oncology, 2012 - ncbi.nlm.nih.gov
Active immunotherapy targeting dendritic cells (DCs) has shown great promise in preclinical
models and in human clinical trials for the treatment of malignant disease. Sipuleucel-T …

Clinical development of Listeria monocytogenes-based immunotherapies.

DT Le, TW Dubenksy Jr, DG Brockstedt - Seminars in Oncology, 2012 - europepmc.org
Active immunotherapy targeting dendritic cells (DCs) has shown great promise in preclinical
models and in human clinical trials for the treatment of malignant disease. Sipuleucel-T …

[引用][C] Clinical Development of Listeria monocytogenes―Based Immunotherapies

DT LE, TW DUBENSKY, DG BROCKSTEDT - Seminars in oncology, 2012 - Elsevier